David Bejker is the founder of Affibody. Latest round: Growth. Based in Solna, Sweden.
David Bejker is the President and CEO of Affibody Medical AB, a biotechnology company based in Solna, Sweden focused on radiopharmaceuticals and Affibody molecules for chronic pain and urology applications. He leads the company that launched a $29 million rights issue in late January 2026 to fund its expanding pipeline, fully guaranteed by its lead shareholder. Bejker is the key executive overseeing Affibody's strategic direction and pipeline development.
Full founder directory · Investor directory · Company funding database · Fundraising library